Announcements Trials
Browse Landscape

Phase

Phase 1/2 2

Status

Recruiting 2Completed 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Myeloid 2Lymphoid 1

Conditions

Leukemia, Myeloid, Acute 3Myelodysplastic Syndromes 2Hematologic Neoplasms 2Triple Negative Breast Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Myelodysplastic-Myeloproliferative Diseases 1Mycoses 1Mucormycosis 1Genetic Predisposition to Disease 1Candidiasis 1Breast Neoplasms 1Aspergillosis 1

Interventions

venetoclax 27fludarabine 26Cyclophosphamide 25Specimen Handling 21Azacitidine 20Biopsy 15Whole-Body Irradiation 14Stem Cell Transplantation 13Decitabine 13Cytarabine 13Tacrolimus 12Melphalan 12fludarabine phosphate 11Mycophenolic Acid 11Busulfan 11Injections 8X-Rays 7Thiotepa 7Hematopoietic Stem Cell Transplantation 7Granulocyte Colony-Stimulating Factor 7decitabine and cedazuridine drug combination 6Cyclosporine 6ruxolitinib 5Magnetic Resonance Spectroscopy 5Idarubicin 5Filgrastim 5gilteritinib 4Sirolimus 4Peripheral Blood Stem Cell Transplantation 4Cyclosporins 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Myelodysplastic Syndromes × posaconazole × Clear all
NCT07155226 2026-05-19

MOMENTUM

AstraZeneca

Phase 1/2 Recruiting
84 enrolled
LymphoidMyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04771130 2026-04-23

A Study of BGB-11417 in Participants With Myeloid Malignancies

BeOne Medicines

Phase 1/2 Recruiting
260 enrolled
MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Myelodysplastic-Myeloproliferative Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡